Factors influencing secondary vibriocidal immune responses: Relevance for understanding immunity to cholera

Infection and Immunity

Volumn 64, Issue 1, 1996, Pages 10-15

  Losonsky, Genevieve A ^a   Yunyongying, Jennie ^a   Lim, Vincent ^a   Reymann, Mardi ^a   Lim, Yu Leong ^a   Wasserman, Steve S ^a   Levine, Myron M ^a  

^a Division of Emergency Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ACTIVE IMMUNIZATION; ADULT; ANTIBODY RESPONSE; ARTICLE; BACTERICIDAL ACTIVITY; CHOLERA; DRUG EFFICACY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; MALE; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIBRIO CHOLERAE;

EID: 0030025939     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.1.10-15.1996     Document Type: Article

References (26)

1. Ahmed, A., A. K. Bhattacharjee, and W. H. Mosley. 1970 Characteristics of the serum vibriocidal and agglutinating antibodies in cholera cases and in normal residents of the endemic and non-endemic cholera areas. J Immunol. 105:431-441
2. Black, R. E., M. M. Levine, M. L. Clements, C. R. Young, A. M. Svennerholm, and J. Holmgren. 1987. Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin. Infect Immun. 55:1116-1120.
3. Champsaur, H., S. Iscaki, O. Bernard, and A. Dodin. 1983. Induction of Vibrio cholerae specific biliary antibodies after oral immunization with a cholera cell-wall fraction. Lancet 1:1276-1277
4. Chitnis, D. S., K. D. Sharma, and R. S. Kamat. 1982. Role of somatic antigen of Vibrio cholerae in adhesion to intestinal mucosa. J. Med. Microbiol. 5:53-61.
5. Clemens, J. D., F. van Loon, D. A. Sack, J. Chakraborty, M. R. Rao, F. Ahmed, J. R. Harris, M. R. Khan, M. Yunus, S. Hilda, B. A. Kay, A. M. Syennerholm, and J. Holmgren. 1991. Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera J. Infect. Dis. 163:1235-1242
6. Clements, M. L., M. M. Levine, C. R. Young, R. E. Black, Y. L. Lim, R. M. Robins-Browne, and J. P. Craig. 1982 Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of vibrio cholerae. J. Infect Dis 145:465-473.
7. Feely, J-C. 1965. Passive protective activity of antisera in infant rabbits infected orally with Vibrio cholerae. p 231-235. In Proceedings of Cholera Research Symposium. PHS publication 1328 U.S. Government Printing Office. Washington, D.C.
8. + subset activity in vivo. J. immunol. 151:48-59.
9. Glass, R. I., A. M. Svennerholm, M. R. Khan, S. Huda, M. I. Huq, and J. Holmgren. 1985. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels and protection. J. Infect Dis. 151:236-242.
10. Holmgren, J., and A. M. Svennerholm. 1977. Mechanisms of disease and immunity in cholera: a review. J Infect. Dis. 136:S105-S112.
11. Kaper, J. B., H. Lockman, M. M. Baldini, and M. M. Levine. 1984. A recombinant live oral cholera vaccine Bio/Technology 2:345-349.
12. Kunimoto, D. Y., G. R. Harriman, and W. Strober. 1988. Regulation of IgA differentiation in CH12LX B cells by lymphokines. IL-4 induces membrane IgM positive CH12LX cells to express membrane IgA and IL-5 induces membrane IgA-positive CH12LX cells to secrete IgA. J. Immunol. 141:713-720
13. Levine, M. M., R. E. Black, M. L. Clements, L. Cisneros, D. R. Nalin, and C. R. Young. 1981. Duration of infection derived immunity to cholera. J. Infect Dis 143:818-820.
14. Levine, M. M., J. B. Kaper, D. Herrington, G. A. Losoasky, J. Ketley, C. O. Tacket, B. Tall, and S. Cryz. 1988 Safety, imrnunogenicity, and efficacy of recombinant live oral cholera vaccines. CVD 103 and CVD 103-HgR. Lancet ii:2467-2470
15. Losonsky, G. A., C. O. Tacket, S. S. Wasserman, J. B. Kaper, and M. M. Levine. 1993. Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection Infect Immun. 61:729-733
16. Mosley, W. H. 1969. The rote of immunity in cholera: a review of epidemiological and serological studies. Tex Rep. Biol. Med 27(Suppl. 1):227-240
17. Mosley, W. H., S. Ahmad, A. S. Benenson, and A. Ahmed. 1968. The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients. Bull. W.H.O. 38:777-785.
18. Mosley, W. H., A. S. Benenson, and R. Barui. 1968. A serological survey for cholera antibodies in rural East Pakistan. 1 The distribution of antibody in the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera. Bull. W.H.O 38:327-334.
19. Neoh, S., and D. Rowley. 1970. The antigens of Vibrio choleiae involved in the vibriocidal action of antibody and complement. J. Infect. Dis. 121:505-513.
20. Nusslein, H. G., and H. L. Spiegellberg. 1990. Interleukin-4 induces both IgG4 and IgE secretion by peripheral blood cells J. Clin Lab. Anal. 4:414-419.
21. Owen, R. L., N. F. Pierce, R. T. Apple, and W. C. Cray, Jr. 1986. M cell transport from the intestinal lumen into Peyer's patches, a mechanism for antigen sampling and for microbial transepithelial migration. J. Infect Dis. 153:1108-1118.
22. Pierce, N. F., J. B. Kaper, J. J. Mekalanos, W. C. Cray, Jr., and K. Richardson. 1987 Determinants of imrnunogenicity of live virulent and mutant Vibrio cholerae O1 in rabbit intestine. Infect. Immun. 55:177-181.
23. Robbins, J. B., K. Kenney, and E. I. Suter. 1965. The isolation and biological activities of rabbit gamma-M and gamma-G-anti-Salmonella typhimurium antibodies J. Exp. Med. 122:385-402.
24. Sumaya, C. V., Y. Ench, M. A. Carrillo, and R. M. Pope. 1984. Use of a simple separation column in detection of immunoglobulin M antibody to Epstein-Barr virus J Clin Microbiol. 20:298-299
25. Tacket, C. O., G. A. Losonsky, J. P. Nataro, S. J. Cryz, R. Edelman, J. B. Kaper, and M. M. Levine. 1992. Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR. Infect. Dis. 166:837-841
26. Yamamoto, T., and T. Yokota. 1989. Vibrio cholerae O1 adherence to human small intestinal M cells in vitro. J. Infect. Dis. 160:168-169.